Stockreport

Covid Report: Moderna Stock Flies On Plans To Begin Phase 2 Vaccine Test [Investor's Business Daily]

Moderna, Inc.  (MRNA) 
Last moderna, inc. earnings: 2/26 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: marinabio.com/investor-relations
PDF Related news Moderna ( MRNA ) is preparing to begin a Phase 2 study of its coronavirus vaccine, the biotech said as MRNA stock popped Tuesday. Late Monday, Moderna said [Read more]